|
GENERAL INFORMATION |
|
|||||
|
Accommodations Accommodations for the conference are at the Minoa Palace Hotel. The hotel is located in Platanias, 24 km from Chania International Airport and 12 km west of Chania town center. Arrival and Check-in It is expected that attendees will arrive/check-in on Saturday after 2:00 PM. Anyone arriving after 10:30 pm on Sunday must make alternative dinner arrangements.
Conference Venue The Minoa Palace Conference Center is located at the hotel.
Handicapped Accessibility The site is fully handicapped accessible.
Oral Presentations Speakers are asked to bring their USB flash drive to the reception desk at least 30 minutes prior to the session. The allocated time for all presentations, unless otherwise indicated, includes five minutes Q&A.
City Tour Buses for the city tour will depart from the hotel front lobby on Tuesday, September 30 at 3:00 pm. Badges are required for participation. BreakfastBreakfast for registered participants and registered accompanying persons will be served at the Minoa Palace Hotel main restaurant during the hours scheduled in this program.
Lunches/Informal Discussions Lunches for registered participants and registered accompanying persons will be served during the times indicated in this program at the main restaurant. Badges are required for admission.
Dinners/Informal Discussions Three of the dinners/informal discussion will be served during the times indicated in the program. Vegetarian entrees are available only upon request in advance of the meeting. Please contact info@aegeanconferences.org.
Internet, Phone, & Computer Wireless Internet access is located throughout the conference center free of charge during meeting hours. There are computers available in the hotel’s business center for the use of the attendees. Phone service is available for an additional charge from your hotel room.
Certificate of Participation A Certificate of Participation will be distributed to a participant for those sessions that the participant has attended. A participant must attend an entire session to receive credit for that particular session. Late arrivals and early departures from a session will preclude a participant from receiving credit for that session.
Other Information Animals are not permitted on site. Badges are required for admission to all events. All Aegean Conferences events are non-smoking.
No Photographs and Recording Devices Participants are not allowed to photograph and/or record using cameras, mobile telephones and other recording devices during the slide and poster presentations.
|
|
|||||
|
Saturday, September 27 |
|
|||||
|
|
|
|
|
|||
|
6:00-8:00 PM |
Conference Registration at the Hotel Lobby |
|
||||
|
|
|
|
|
|||
|
8:00 PM |
|
Welcome Reception/Dinner |
|
|||
|
|
|
|
|
|||
|
Sunday, September 28 |
|
|||||
|
|
|
|
|
|||
|
8:00 AM |
|
Breakfast |
|
|||
|
|
|
|
|
|||
|
8:50 AM |
|
Welcome / Opening Remarks |
|
|||
|
|
|
|
|
|||
|
Session I |
|
Thromboinflammation |
|
|||
|
|
|
Chairs: Diana Karpman and Gregory Stahl |
|
|||
|
9:00 AM |
1 |
Therapeutic regulation of thromboinflammation induced by biosurfaces |
|
|||
|
|
|
Bo Nilsson |
|
|||
|
9:25 AM |
2 |
Complement and kinin system interactions with blood cells, endothelial cells and microvesicles |
|
|||
|
|
|
Diana Karpman |
|
|||
|
9:50 AM |
3 |
Role of complement on broken surfaces after trauma |
|
|||
|
|
|
Markus S Huber-Lang, S Denk, R Wiegner, S Weckbach, A Ignatius, and R Brenner |
|
|||
|
10:15 AM |
4 |
Biomaterials and non-self: The complement system and beyond |
|
|||
|
|
|
Tom E Mollnes |
|
|||
|
10:40 AM |
5 |
Bringing Mesenchymal stem cells into the clinic |
|
|||
|
|
|
Katarina Le Blanc |
|
|||
|
|
|
|
|
|||
|
11:05 AM |
|
Coffee Break & Poster Viewing |
|
|||
|
|
|
|
|
|||
|
Session II |
|
Host response to biomaterials |
|
|||
|
|
|
Chairs: Dianne Burgess and Peter Thomsen |
|
|||
|
11:50 AM |
6 |
Biomaterial-associated inflammation and tissue regeneration: cell-cell communication and novel roles of exosomes and microvesicles |
|
|||
|
|
|
Peter Thomsen |
|
|||
|
12:15 PM |
7 |
Foreign body reaction to implanted miomaterials: Disease models and inter-species differences |
|
|||
|
|
|
Diane Burgess, Michail Kastellorizios, Yan Wang, and Fotios Papadimitrakopoulos |
|
|||
|
12:40 PM |
8 |
A novel biomarker for biocompatibility based on protein fingerprint from plasma to biomaterials in contact with human blood |
|
|||
|
|
|
Kristina Nilsson Ekdahl |
|
|||
|
1:05 PM |
9 |
Unique macrophage polarization and NFkB activation following interaction with biomaterial surfaces |
|
|||
|
|
|
Laura Beth Moore, Andrew J Sawyer, Antonios Charokopos, Eleni A Skokos, and Themis R Kyriakides |
|
|||
|
1:30 PM |
10 |
Tooth-associated biofilm and complement-mediated inflammatory responses in the periodontal tissue |
|
|||
|
|
|
Georgios Hajishengallis, Tomoki Maekawa, Toshiharu Abe, Evlambia Hajishengallis, Robert A DeAngelis, Daniel Ricklin, and John D Lambris |
|
|||
|
|
|
|
|
|||
|
1:55 PM |
|
Lunch / Informal Discussions |
|
|||
|
|
|
|
|
|||
|
7:30 PM |
|
Dinner / Informal Discussions at a local Greek Taverna Buses depart from the hotel lobby at 7:30 PM |
|
|||
|
|
|
|
|
|||
|
Monday, September 29 |
|
|||||
|
|
|
|
|
|||
|
8:00 AM |
|
Breakfast |
|
|||
|
|
|
|
|
|||
|
Session III |
|
Transplantation I |
|
|||
|
|
|
Chairs: Katarina LeBlanc and Ali Naji |
|
|||
|
9:00 AM |
11 |
The many ways patents are used to add value |
|
|||
|
|
|
Janet E Reed |
|
|||
|
9:25 AM |
12 |
Systemic inflammation and cardiovascular disease in renal failure |
|
|||
|
|
|
Bengt Fellström |
|
|||
|
9:50 AM |
13 |
C5-blockade and complement monitoring for high-risk ABO-incompatible transplantations |
|
|||
|
|
|
Alireza Biglarnia, Erik Larsson, Kristina Nilsson-Ekdahl, and Bo Nilsson |
|
|||
|
10:15 AM |
14 |
Islet transplantation and the prospect of achieving tolerance |
|
|||
|
|
|
Ali Naji, Malek Kamoun, Michael Rickels, and Chengyang Liu |
|
|||
|
10:40 AM |
15 |
Endothelial cell injury and complement activation |
|
|||
|
|
|
Gregory L Stahl |
|
|||
|
|
|
|
|
|||
|
11:05 AM |
|
Coffee Break & Poster Viewing |
|
|||
|
|
|
|
|
|||
|
Session IV |
Drugs, drug delivery systems and scaffolds |
|
||||
|
|
|
Chairs: Triantafillos Chavakis and Kristina N Ekdahl |
|
|||
|
11:50 AM |
16 |
Cp40: a complement inhibitor getting ready for primetime |
|
|||
|
|
|
John D Lambris, Edimara S Reis, Alexandra Primikyri, Malvina Papanastasiou, Sophia Koutsogiannaki, Gang Chen, Markus Huber-Lang, Bo Nilsson, Alireza Biglarnia, Antonio M Risitano, George Hajishengallis, Despina Yancopoulou, Robert A DeAngelis, and Daniel Ricklin |
|
|||
|
12:15 PM |
17 |
A novel bacterially inspired method for making biocompatible surfaces |
|
|||
|
|
|
Andrew P Herbert, Elisavet Makou, and Paul N Barlow |
|
|||
|
12:40 PM |
18 |
SOBI002 - a novel complement component C5 inhibitor for efficient therapeutic targeting of the terminal complement pathway |
|
|||
|
|
|
Magnus M Berglund, Lotta Berghard, Per-Olof Edlund, Carina Ekholm, Jaan Hong, Susanne Lindblom, Lillemor Stenbeck Funke, Catharina Sterky, Chao Su, Charlotte Söderberg Nyhem, Kristina Nilsson Ekdahl, Bo Nilsson, and Patrik Strömberg |
|
|||
|
1:05 PM |
19 |
Biopolymer mediated delivery of chemotherapeutic agents for cancer specific cytotoxicity without inducing haemotoxicity |
|
|||
|
|
|
Oommen P Oommen and Jöns Hilborn |
|
|||
|
1:20 PM |
20 |
Nanoscale transport system for drug delivery based on amphiphilic polymers |
|
|||
|
|
|
Pavel Pavlovich Kulikov, Andrey Nikolaevich Kuskov, Mikhail Isaakovich Shtilman, and Aristidis Michael Tsatsakis |
|
|||
|
1:35 PM |
21 |
Inflammatory and hemostatic activation induced by alginate microcapsules reveals novel mechanisms underlying their biocompatibility |
|
|||
|
|
|
Anne Mari Rokstad, Mathias P Ørning, Shamal Hamad, Kine Samseth Hoem, Bjørg Steinkjer, Hilde Fure, Liv Ryan, Igor Lacik, Tom Eirik Mollnes, Ole Lars Brekke, and Terje Espevik |
|
|||
|
1:50 PM |
22 |
Bio-nano interface interactions between iron oxide MRI contrast agents and innate immune system |
|
|||
|
|
|
Nirmal K Banda, Gaurav Mehta, Ying Chao, Igor F Tsigelny, Guankui Wang, Swetha Inturi, Liliane Fossati-Jimack, Marina Botto, LinPing Wu, Seyed Moein Moghimi, and Dmitri Simberg |
|
|||
|
|
|
|
|
|||
|
2:05 PM |
|
Lunch / Informal Discussions |
|
|||
|
|
|
|
|
|||
|
7:30 PM |
|
Dinner / Informal Discussions at a local Greek Taverna Buses depart from the hotel lobby at 7:30 PM |
|
|||
|
|
|
|
|
|||
|
Tuesday, September 30 |
|
|||||
|
|
|
|
|
|||
|
8:00 AM |
|
Breakfast |
|
|||
|
|
|
|
|
|||
|
Session V |
|
Biomodulating surfaces I |
||||
|
|
|
Chairs: Hans Elwing and Duncan Sutherland |
||||
|
9:00 AM |
23 |
The acute inflammatory responses in blood are attenuated by surface nanotopograpy |
||||
|
|
|
Hans Elwing |
||||
|
9:25 AM |
24 |
Probing protein interactions at nanomaterials |
||||
|
|
|
Duncan Sutherland |
||||
|
9:50 AM |
25 |
A trinity of importance: biosurfaces, the ultrastructure of complement proteins, and the nanoscience of complement activation |
||||
|
|
|
Thomas Vorup-Jensen |
||||
|
10:15 AM |
26 |
Biomimetic materials through molecular imprinting: Fundamentals and applications |
||||
|
|
|
Ian A Nicholls |
||||
|
10:40 AM |
27 |
Issues with protein delivery for bone regeneration |
||||
|
|
|
Jöns Hilborn, Oommen Varghese, Oommen P Oommen and Dmitri Ossipov |
||||
|
|
|
|
||||
|
11:05 AM |
|
Coffee Break & Poster Viewing |
|
|||
|
|
|
|
||||
|
Session VI |
Transplantation II |
|||||
|
|
|
Chairs: Jeffrey L Platt and Bruno Reichart |
||||
|
11:35 AM |
28 |
German Research Foundation, Transregio CRC 127 Xenogenic cell and organ transplantation – from the bench to the clinic |
||||
|
|
|
Bruno Reichart |
||||
|
12:00 PM |
29 |
Inflammation and the fate of autogenous and grafted tissues |
||||
|
|
|
Jeffrey L Platt and Marilia Cascalho |
||||
|
12:25 PM |
30 |
Preparation of immune-privileged site for all-islet transplantation by agarose-FGF2 complex |
||||
|
|
|
Nguyen Minh Luan and Hiroo Iwata |
||||
|
12:50 PM |
31 |
Islet Xenotransplantation: are we ready for clinical islet xenotransplantation? Use of a subcutaneous monolayer cellular device containing pig islets to treat diabetic primates without Immunosupression |
||||
|
|
|
Pierre Gianello |
||||
|
1:15 PM |
32 |
Controlling the response to allogeneic and xenogeneic surfaces in organ transplantation |
||||
|
|
|
Peter J Cowan and Bo Lu |
||||
|
1:40 PM |
33 |
Inhibitors of leukocyte recruitment |
||||
|
|
|
Triantafyllos Chavakis, Ioannis Mitroulis, Rashim Pal Singh, Lan-Sun Chen, Eun Young Choi, Jong-Hyung Lim, Jindra Chmelar, Kyoung-Jin Chung, and George Hajishengallis |
||||
|
|
|
|
||||
|
2:05 PM |
|
Lunch / Informal Discussions |
|
|||
|
|
|
|
|
|||
|
3:30 PM |
|
Sightseeing and a guided walking tour in old town of Chania Buses depart from the hotel lobby at 3:30 PM |
|
|||
|
|
|
|
|
|||
|
7:30 PM |
|
Dinner / Informal Discussions at a local Greek Taverna Dinner to follow the tour. Buses do not return prior to dinner. |
|
|||
|
|
|
|
||||
|
Wednesday, October 1 |
||||||
|
|
|
|
||||
|
8:00 AM |
|
Breakfast |
|
|||
|
|
|
|
|
|||
|
Session VII |
|
Extracorporeal circulation |
||||
|
|
|
Chairs: Peter Garred and Daniel Ricklin |
||||
|
9:00 AM |
34 |
Heparin coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule Ficolin-2 of the lectin complement pathway in vivo |
||||
|
|
|
Estrid Hein, Lea Munthe-Fog, Amrit Singh Thiara, Arnt E Fiane, Tom Eirik Mollnes, and Peter Garred |
||||
|
9:25 AM |
35 |
Del-1 regulates the intravascular innate immune responses in islet xeno-transplantation |
||||
|
|
|
Ioannis Kourtzelis, Ioannis Mitroulis, Anaisa Ferreira, Anja Steffen, Barbara Ludwig, Claudia Waskow, and Triantafyllos Chavakis |
||||
|
9:40 AM |
36 |
Role of complement in the inflammatory response to intravascular hemolysis |
||||
|
|
|
Per H Nilsson, Kari Otterdal, Stig Nymo, Margareta Nilsson, Pal Aukrust, and Tom Eirik Mollnes |
||||
|
9:55 AM |
37 |
Calcium-containing particles induce cell toxicity and inflammation which can be reduced by the presence of citrate |
||||
|
|
|
Viktoria Hancock, Emma Lindeberg, and Gunilla Grundström |
||||
|
10:10 AM |
38 |
A case for complement-targeted intervention in hemodialysis: Insight from in vitro studies and non-human primate models |
||||
|
|
|
Daniel Ricklin, Edimara S Reis, Robert A DeAngelis, Zhuoer Lin, Sophia Koutsogiannakis, Hui Chen, Ranillo RG Resuello, and John D Lambris |
||||
|
|
|
|
||||
|
10:35 AM |
|
Coffee Break & Poster Viewing |
|
|||
|
|
|
|
||||
|
Session VIII |
Biomodulating surfaces II |
|||||
|
|
|
Chairs: George Hajishengallis and Jöns Hilborn |
||||
|
11:15 AM |
39 |
Evaluation of vascular disease – a novel in vitro model for studying the interactions between human whole blood and endothelium |
||||
|
|
|
Peetra U Magnusson |
||||
|
11:40 |
40 |
Alternative pathway of complement activation on biomaterials; A role for Factor seven activating protease (FSAP) |
||||
|
|
|
Claudia Sperling, Sandip M Kanse, Simona Grasso, and Carsten Werner |
||||
|
12:05 PM |
41 |
Cell surface engineering with biomaterials for islet transplantation |
||||
|
|
|
Yuji Teramura |
||||
|
12:30 PM |
42 |
Protective role of PEG conjugated phospholipid in reducing ischemic reperfusion injury in an en bloc allogeneic pig kidney transplant model. |
||||
|
|
|
Sana Asif, Yuji Teramura, Kristina Nilsson Ekdahl, Bo Nilsson, and Alireza Biglarnia |
||||
|
12:45 PM |
43 |
Improving a Factor H-binding peptide (5C6) for complement-targeted therapy |
||||
|
|
|
Sophia Koutsogiannaki, Zhuoer Lin, Christoph Q Schmidt, Kristina N Ekdahl, Bo Nilsson, Daniel Ricklin, and John D Lambris |
||||
|
1:00 PM |
44 |
Development and application of mouse and pig complement immunoassays |
||||
|
|
|
Geurt Schilders, Aswin Jansen, and Jan van Binsbergen |
||||
|
1:15 PM |
45 |
Modelling of a targeted nanotherapeutic "stroma" to deliver LIF, or XAV939, for use in primary human fetal dopaminergic grafts in Parkinson's disease |
||||
|
|
|
Su Metcalfe, Jing-Wei Zhao, Tarek M Fahmy, and Roger A Barker |
||||
|
|
|
|
|
|||
|
1:30 PM |
|
Closing Remarks |
|
|||
|
|
|
|
|
|||
|
2:00 PM |
|
Lunch / Informal Discussions |
|
|||
|
|
|
|
|
|||
|
8:00 PM |
|
Farewell Dinner |
|
|||
|
|
|
|
||||
|
Thursday, October 2 |
||||||
|
|
|
|
||||
|
8:00 AM |
|
Breakfast |
|
|||
|
|
|
|
|
|||
|
|
|
Departure
|
||||
|
POSTERS |
||||||
|
|
|
|
||||
|
46 |
Complement inhibition in a xenogeneic model of interactions between human whole blood and porcine endothelium |
|||||
|
|
Ioannis Kourtzelis, Anaisa Ferreira, Ioannis Mitroulis, John D Lambris, Claudia Waskow, and Triantafyllos Chavakis |
|||||
|
47 |
Creation of an anti thrombogenic surface by incorporating heparin-binding peptides to Tri-block copolymers |
|||||
|
|
Sana Asif, Karin Fromell, Kristina Nilsson Ekdahl, Yuji Teramura, and Bo Nilsson |
|||||
|
48 |
Hemodialysis biomaterials induce complement-dependent formation of neutrophil extracellular traps |
|||||
|
|
Ioannis Kourtzelis, Ioannis Mitroulis, Anaisa Ferreira, Konstantinos Kambas, John D Lambris, Konstantinos Ritis, and Triantafyllos Chavakis |
|||||
|
49 |
Human mast cell response to nanosurfaces: balancing innate and adaptive immunity |
|||||
|
|
Marianna Kulka |
|||||
|
50 |
Material specific tissue responses: Adverse reaction to metallic debris beyond metal-on-metal hip replacement |
|||||
|
|
Zhidao Xia, and Giorgio Perino |
|||||
|
51 |
Prevention of thrombogenesis from whole human blood on hemoperfusion materials |
|||||
|
|
Michael Thompson, Kiril Fedorov, Christophe Blaszykowski, and Sonia Sheikh |
|||||
|
52 |
Seaweed myocardial regeleration: New biology of the alginate-myocardial microenvironment |
|||||
|
|
Jay W Schneider |
|||||
|
53 |
Surface modification of primary human hepatocytes with recombinant CD39 protects against thromboinflammation |
|||||
|
|
Nina Jonsson, Asif Sana, Teramura Yuji, Kristina Ekdahl-Nilsson, Nilsson Bo, and Elisabet Gustafsson |
|||||
|
54 |
The lectin complement pathway serine proteases (MASPs) represent a major crossroad between activation of the coagulation and complement systems in thromoinflammation. |
|||||
|
|
Huda Kozarcanin, Kristina Nilsson-Ekdahl, Peetra Magnusson, and Bo Nilsson |
|||||
|
55 |
Vascular repair utilizing immobilized heparin conjugate for protection against early activation of inflammation and coagulation |
|||||
|
|
Sofia Nordling, Jaan Hong, Karin Fromell, Fredrik Edin, Johan Brännström, Rolf Larsson, Bo Nilsson, and Peetra U Magnusson |
|||||
|
56 |
Validations of assays for the evaluation of C1q in inflammatory diseases and thromboinflammation |
|||||
|
|
Kerstin Sandholm, Elisabeth Wijkström, Lillemor Skattum, Bo Nilsson, and Kristina N Ekdahl |
|||||
|
57 |
Development of an in vitro test for innate immunity and blood compatibility of scaffolds and cell/scaffold constructs |
|||||
|
|
Jaan Hong |
|||||